Life Science Company News

Reset
Results 101 - 120 out of 500 displayed.
«  1  2  3  4  5 6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

BioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In Cohort

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  BioCardia, Inc.

Precision Optics Announces Receipt of $1.26 Million Follow On Production Order from Large Defense Company

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Precision Optics Corporation, Inc.

Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Aclarion

GRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  GRI Bio Inc.

Using AI to Improve Diagnosis of Rare Genetic Disorders

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Baylor Genetics

Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Mainz Biomed N.V.

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Orion Oyj

RS BioTherapeutics Adds Jane Wright-Mitchell, Pharm.D., J.D. to Business Advisory Board

Read more ››
By: GlobeNewswire - 25 Apr 2024

Tiziana Life Sciences Reports Positive 3-Month Neuroimaging Scores in Multiple Sclerosis Patients Receiving Intranasal Foralumab

Read more ››
By: GlobeNewswire - 25 Apr 2024

Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Nexalin Technology Inc

Ibogaine Treatment for Borderline Personality Disorder Launched by Ibogaine By David Dardashti

Read more ››
By: GlobeNewswire - 25 Apr 2024

Guerbet : Q1 2024 revenue.

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Guerbet SA

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Oxurion NV

CARBIOS celebrates the groundbreaking of its PET biorecycling plant, a world first, with its partners

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Carbios SA

Vilya Announces New Publication in Science Validating Foundational Approach to Design of Novel Chemically Diverse Macrocycles

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Vilya, Inc.

Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Progyny, Inc.

Onconic Therapeutics Receives MFDS Approval for JAQBO, a New Treatment for Gastroesophageal Reflux Disease (GERD)

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024
Related companies:  Onconic Therapeutics

On-Device AI Healthcare Company Noul Announces 2 Clinical Performance Studies at Pan-African Malaria Conference

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024
Related companies:  Noul Co., Ltd.

Hyundai Bioscience's antiviral for Dengue Fever to enter clinical trials in Brazil

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024
Related companies:  Hyundai Bioscience Co. Ltd

2024 ASCO | Mabwell to Present Clinical Data of 9MW2821 in Multiple Advanced Solid Tumor

Read more ››
By: PR Newswire Association LLC. - 25 Apr 2024
Related companies:  Mabwell Biotech Co.,Ltd.
Results 101 - 120 out of 500 displayed.
«  1  2  3  4  5 6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »